The use of belatacept in kidney transplantation
Background. Kidney transplantation efficacy is limited by immunosuppression nephrotoxicity, antibody-mediated and chronic rejection. Avoiding immunosuppression nephrotoxicity is a promising strategy to improve long term outcomes. Belatacept, a synthetic immunoglobulin which blocks CD28-B7 pathway of...
Kaydedildi:
| Asıl Yazarlar: | , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
N.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department
2018-09-01
|
| Seri Bilgileri: | Трансплантология (Москва) |
| Konular: | |
| Online Erişim: | https://www.jtransplantologiya.ru/jour/article/view/394 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|